4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Diseaseidiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorderEnrolling by invitationPhase 32026-10-06NCT04905693
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertensionlung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorderActive, not recruitingPhase 32026-10-06NCT04273945
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)Hypoxia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorderRecruitingNot stated2026-08-26NCT06388421
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorderRecruitingPhase 32026-07-29NCT06274801